Nitroimidazole antibiotic / antiprotozoal
Pregnancy: Use with caution in first trimester; widely used in second/third trimester for bacterial vaginosis and trichomoniasis. Single-dose regimen preferred.
Metronidazole
Brand names: Flagyl, Metronidazole
Adult dose
Dose: Anaerobic infections: 400 mg TDS oral or 500 mg TDS IV; C. difficile (mild-moderate): 400–500 mg TDS for 10 days
Route: Oral, IV, or PR (suppository)
Frequency: Three times daily
Max: 4 g/day
Anaerobic prophylaxis (surgical): 500 mg IV at induction. Bacterial vaginosis: 400 mg BD for 5–7 days oral or 0.75% gel intravaginally. Trichomoniasis: 2 g single dose or 400 mg BD for 5–7 days. Giardiasis: 400 mg TDS for 5 days. C. difficile mild: 400–500 mg TDS for 10 days (vancomycin oral preferred for severe/recurrent).
Paediatric dose
Dose: 7.5 mg/kg
Route: Oral or IV
Frequency: Three times daily
Max: 400 mg/dose
Concentration: 5 mg/ml
1 month–11 years: 7.5 mg/kg TDS. ≥12 years: adult dose. C. difficile: 7.5 mg/kg TDS for 10 days. Giardiasis: 2 mg/kg (max 400 mg) TDS for 5 days. Surgical prophylaxis: 7.5 mg/kg IV at induction.
Dose adjustments
Renal
No dose adjustment required for short courses. Prolonged use in severe renal failure — monitor for accumulation.
Hepatic
Reduce dose in severe hepatic impairment; accumulation of active metabolites.
Paediatric weight-based calculator
1 month–11 years: 7.5 mg/kg TDS. ≥12 years: adult dose. C. difficile: 7.5 mg/kg TDS for 10 days. Giardiasis: 2 mg/kg (max 400 mg) TDS for 5 days. Surgical prophylaxis: 7.5 mg/kg IV at induction.
Clinical pearls
- Excellent anaerobic coverage — cornerstone of surgical prophylaxis combined with cephalosporin
- Avoid alcohol during treatment AND 48 hours after last dose
- For severe/recurrent C. difficile: vancomycin oral 125 mg QDS is superior
- Peripheral neuropathy with prolonged use (>10 days) — monitor and stop if symptoms
- IV and oral preparations have equivalent bioavailability — switch to oral when tolerated
Contraindications
- Hypersensitivity to metronidazole or other nitroimidazoles
Side effects
- Nausea, metallic taste
- Peripheral neuropathy (prolonged use)
- Disulfiram-like reaction with alcohol
- Seizures (high doses or CNS disease)
- Dark urine (harmless)
- Elevated LFTs
Interactions
- Alcohol — disulfiram-like reaction (nausea, vomiting, flushing) — avoid alcohol during treatment and 48 hours after
- Warfarin — significantly increases INR (reduce warfarin dose, monitor closely)
- Lithium — can increase lithium levels
- Phenytoin — increases phenytoin levels
- Disulfiram — avoid concomitant use (psychosis risk)
Monitoring
- LFTs (prolonged use)
- Signs of neuropathy
- Drug interactions (especially warfarin)
Reference: BNFc; BNF; PHE guidelines; ECDC C. difficile guidelines. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- FeverPAIN Score for Strep Throat · Throat
- Jarisch-Herxheimer Reaction Severity Assessment · Treatment Reactions
- PID Severity (CDC Diagnostic Criteria) · Gynaecological Infections
- Gustilo-Anderson Classification (Open Fractures) · Fracture Classification
- DRIP Score for Drug-Resistant Pneumonia · Pneumonia
Pathways
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023